3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
5
Head & Neck
2
Genitourinary
2
Gastrointestinal
2
Breast
2
Sarcoma
1
Lymphoid
1
Gynecologic
1
Conditions
Sarcoma
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Lymphoma
1
Lung Neoplasms
1
Kidney Neoplasms
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Interventions
pembrolizumab
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Cyclophosphamide
5
Radiosurgery
3
Oncolytic Virotherapy
3
Nivolumab
3
Injections
3
Gemcitabine
3
Drug Therapy
3
Biopsy
3
fludarabine
2
belinostat
2
Riluzole
2
Paclitaxel
2
Ipilimumab
2
Filgrastim
2
Docetaxel
2
Cisplatin
2
Celecoxib
2
Carboplatin
2
Bortezomib
2
Blood Specimen Collection
2
Amifostine
2
AH 111585
2
tislelizumab
1
spartalizumab
1
seribantumab
1
selpercatinib
1
sargramostim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Referral and Consultation
×
Sarcoma
×
Clear all
NCT02821793
2025-07-01
PRIORITY
Institut Bergonié
Completed
346 enrolled
9 charts